Company intelligence / Profile preview

MGC Diagnostics

Saint Paul, Minnesota, USAmgcdiagnostics.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

MGC Diagnostics offers a broad portfolio of non-invasive cardiorespiratory diagnostic devices and workflow solutions used globally in hospitals and research centers. Their products are widely adopted for pulmonary function testing and gas exchange analysis. The company recently received FDA clearance for its Ascent™ software platform. No clinical trial results as the company does not develop therapeutics.

Therapeutic areas: PulmonologyCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy (diagnostic systems)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on MGC Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MGC Diagnostics.

Explore the full profile